Serigen receives the DBT-BIRAC-BIPP grant funding

Serigen (previously BiolMed) has been selected for the Biotechnology Industry Partnership Program (BIPP) funding scheme. BIPP is implemented by Biotechnology Industry Research Assistance Council (BIRAC), a Section 8 company setup by the Department of Biotechnology, a Government of India initiative. The funding will enable Serigen  to complete biocompatibility and efficacy studies for its flagship product Serioss. Serioss is an osteoconductive bone void filler that can be used to assist healing of large cavities in bones.